Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: IMHA - New Invest.- Musculoskeletal Health Bridge Funding

Université Laval

$100,000.00

Defining the role of immune cells' energy metabolism in rheumatoid arthritis

FY 2014-15

Summary
More than one million Canadians are affected with inflammatory types of arthritis such as rheumatoid arthritis. Among all causes of disability, arthritis ranks first among women and second among men, costing the Canadian economy more than $30 billions annually. Current therapies are expensive and do not completely eliminate the inflammation or provide a cure, often requiring the usage of multiple treatments concurrently. The underlying causes of rheumatoid arthritis are not completely understood, but it is well established that the progressive joint destruction that occurs during disease progression results from inappropriate activation of cells of the immune system. Immune cells require energy for housekeeping functions as well as for specific immune functions, and alterations in bioenergetics are often associated with diseases such as diabetes and cancer. Energy metabolism of immune cells is increased in patients with rheumatic diseases, suggesting that the assessment of their bioenergetics could be suitable for monitoring disease activity. This present research study will aim to characterize the bioenergetics and intracellular signaling events occurring in the different immune cell types involved in the pathophysiology of rheumatoid arthritis and determine whether therapies can modulate the energy metabolism of these cells. This research will inform us about the diseases and their treatments, leading to new biomarkers and perhaps pave the way for new treatments of inflammatory disorders.
Program
Operating Grant - PA: IMHA - New Invest.- Musculoskeletal Health Bridge Funding
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
329714
Name
Pelletier Martin
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Defining the role of immune cells' energy metabolism in rheumatoid arthritis
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: IMHA - New Invest.- Musculoskeletal Health Bridge Funding
Keyworddelim
Arthritis; Autoimmunity; Cytokine; Energy Metabolism; Inflammation; Rheumatic Diseases
Abstract
More than one million Canadians are affected with inflammatory types of arthritis such as rheumatoid arthritis. Among all causes of disability, arthritis ranks first among women and second among men, costing the Canadian economy more than $30 billions annually. Current therapies are expensive and do not completely eliminate the inflammation or provide a cure, often requiring the usage of multiple treatments concurrently. The underlying causes of rheumatoid arthritis are not completely understood, but it is well established that the progressive joint destruction that occurs during disease progression results from inappropriate activation of cells of the immune system. Immune cells require energy for housekeeping functions as well as for specific immune functions, and alterations in bioenergetics are often associated with diseases such as diabetes and cancer. Energy metabolism of immune cells is increased in patients with rheumatic diseases, suggesting that the assessment of their bioenergetics could be suitable for monitoring disease activity. This present research study will aim to characterize the bioenergetics and intracellular signaling events occurring in the different immune cell types involved in the pathophysiology of rheumatoid arthritis and determine whether therapies can modulate the energy metabolism of these cells. This research will inform us about the diseases and their treatments, leading to new biomarkers and perhaps pave the way for new treatments of inflammatory disorders.
Competitiondate
201503
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pelletier, Martin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
Université Laval - $100,000 Grant (2014-15) | Canada Spends